Takeda: Constipation trials

The registry lists 29 Constipation studies with Takeda as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 1 5Phase 2 6Phase 3 15Phase 4 2No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Prucalopride For Functional Constipation in Children and TeenagersTerminatedNCT04759833Phase 3Results posted
• Lubiprostone for Chronic Idiopathic Constipation TreatmentCompletedNCT02729909Phase 3Results posted
• Lubiprostone for Treatment of Chronic Idiopathic ConstipationCompletedNCT02695719Phase 3Results posted
• Lubiprostone for the Treatment of Chronic Idiopathic ConstipationCompletedNCT02651155Phase 3Results posted
• Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon ActivityCompletedNCT01707667Phase 4Results posted
• Evaluation of Long-term Prucalopride Treatment With Chronic Constipation in Subjects Aged ≥ 18 YearsCompletedNCT01424228Phase 4Results posted
• Prucalopride in Pediatric Subjects With Functional ConstipationCompletedNCT01330381Phase 3Results posted
• Evaluation of Prucalopride in Male Subjects With Chronic Constipation.CompletedNCT01147926Phase 3Results posted
• Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced ConstipationTerminatedNCT01117051Phase 3Results posted
• A Study to Assess Maternal and Fetal Outcomes After Taking Prucalopride During PregnancyActive, not recruitingNCT04961840
• Prucalopride Subjects With Renal ImpairmentCompletedNCT01674192Phase 1
• Single Dose Pharmacokinetics of Prucalopride in Paediatric Subjects, With Functional Faecal RetentionCompletedNCT01674166Phase 1
• Prucalopride in Paediatric Subjects, With Functional Faecal RetentionCompletedNCT01670669Phase 1
• Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic ConstipationCompletedNCT01070615Phase 3
• Study to Evaluate Long-Term Safety, Tolerability, and Satisfaction With Prucalopride in Chronic ConstipationCompletedNCT00987844Phase 3
• Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG ParametersCompletedNCT00903747Phase 1
• Efficacy and Safety Study of Prucalopride for the Treatment of Chronic ConstipationCompletedNCT00631813Phase 2
• Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing FacilityCompletedNCT00627692Phase 2
• Efficacy and Safety Study of Prucalopride for the Treatment of Chronic ConstipationCompletedNCT00617513Phase 2
• Efficacy and Safety Study of Prucalopride for the Re-Treatment of Chronic ConstipationCompletedNCT00598338Phase 3
• Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic ConstipationCompletedNCT00596596Phase 2
• Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic ConstipationCompletedNCT00577018Phase 3
• Effect of Prucalopride in Patients With Severe Chronic Idiopathic ConstipationCompletedNCT00576511Phase 2
• Prucalopride in Patients With Chronic Idiopathic ConstipationCompletedNCT00575614Phase 2
• A Trial in Healthy Volunteers, to Evaluate the Tolerability and Cardiac Safety of PrucaloprideCompletedNCT00488215Phase 1
• Efficacy and Safety Study of Prucalopride to Treat Chronic ConstipationCompletedNCT00488137Phase 3
• Efficacy and Safety Study of Prucalopride for the Treatment of Elderly Patients With Chronic ConstipationCompletedNCT00487422Phase 3
• Efficacy and Safety Study of Prucalopride for the Treatment of Patients With Chronic ConstipationCompletedNCT00485940Phase 3
• Efficacy and Safety Study of Prucalopride for the Treatment of Chronic ConstipationCompletedNCT00483886Phase 3